Summary
By eliminating necessary safeguards for pregnant girls and women who undergo the dangerous mifepristone abortion drug regimen, the U.S. Food and Drug Administration failed to abide by its legal obligations to protect the health, safety, and welfare of girls and women.
Related Articles
Press Releases
-
Image
FDA's recklessness continues for now -
Image
US Supreme Court to hear arguments Tuesday about the FDA's recklessness -
Image
ADF joins members of Congress at press conference Thursday -
Image
ADF to FDA: Women deserve better -
Image
Broad support to protect women's health filed at US Supreme Court -
Image
FDA endangered women's health by removing key safeguards for high-risk abortion drugs -
Image
Biden admin defends FDA's reckless betrayal of women, girls -
Image
District court grants states' request to hold FDA accountable for removing critical safety standards for women and girls -
Image
US Supreme Court to hear case on chemical abortion drugs -
Image
ADF to Supreme Court: Deny Biden admin's request to remove safeguards for chemical abortion drugs -
Image
MO, KS, ID seek to join lawsuit to restore safeguards to chemical abortion drugs -
Image
ADF to US Supreme Court: Keep safeguards in place for chemical abortion drugs -
Image
FDA must restore vital safeguards for chemical abortion drugs, 5th Circuit rules
-
Image
Unlawful FDA approval of chemical abortion drugs before 5th Circuit
-
Image
Lawsuit challenging illegal approval of abortion drugs continues
-
Image
Doctors urge Supreme Court to reject FDA's fight to put women at risk -
Image
Supreme Court issues standard-procedure stay in FDA case -
Image
ADF: Supreme Court should reject FDA's fight to put women at risk -
Image
5th Circuit ends FDA's illegal mail-order abortion regime -
Image
ADF to 5th Circuit: FDA must be held accountable for lawlessness -
Image
FDA's illegal approval of chemical abortion drugs heads to 5th Circuit -
Image
Court halts FDA's unlawful approval of chemical abortion drugs
-
Image
ADF to court: Protect women, girls from dangerous chemical abortion drugs
-
Image
Groups, officials unite to hold FDA accountable for illegally approving chemical abortion drugs -
Image
Doctors, health care groups push back on FDA attempts to justify illegal approval of chemical abortion drugs
-
Image
Doctors, health care groups sue FDA for approving dangerous chemical abortion drugs
Commentary
-
Elizabeth GilletteJuly 08, 2024
-
Erin HawleyJune 20, 2024
-
Erin HawleyJune 19, 2024
-
Kristen WaggonerJune 14, 2024
-
Erik BaptistJune 06, 2024
-
Erik BaptistMay 30, 2024
-
Erik BaptistMay 26, 2024
-
Lathan WattsApril 20, 2024
-
Ryan BangertApril 19, 2024
-
Catherine WheelerApril 03, 2024
-
Kristen WaggonerMarch 28, 2024
-
Erin HawleyMarch 28, 2024
-
Kristen WaggonerMarch 28, 2024
-
Erin HawleyMarch 28, 2024
Case Documents
Court
Title
Date
U.S. Supreme Court
2/26/2024
Trial Court
1/12/2024
U.S. Supreme Court
4/14/2023
U.S. Supreme Court
4/14/2023
U.S. Supreme Court
4/14/2023
Additional Resources
Case Profiles
Image
Erin Morrow Hawley
Senior Counsel, Vice President of Center for Life & Regulatory Practice
Erin Morrow Hawley serves as senior counsel and vice president of the Center for Life and Regulatory Practice at Alliance Defending Freedom.
Image
Erik Baptist
Senior Counsel, Director of the Center for Life
Erik Baptist serves as senior counsel and director of the Center for Life at Alliance Defending Freedom.